Status:
COMPLETED
Substance P as a Biomarker to Evaluate the Reduction of Multiple Immunization Pain
Lead Sponsor:
Jordan University of Science and Technology
Conditions:
Immunisation Anxiety Related Reaction
Pain, Acute
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
Immunization is one of the most significant preventive health measures in reducing morbidity and mortality caused by infectious diseases. Studies have shown that Sucrose is recommended to reduce pain ...
Eligibility Criteria
Inclusion
- All healthy children who were attending immunization clinic to have their 10-24 month immunization were invited to this study
Exclusion
- Exclusion criteria included children: whose parents choose to breastfeed during immunization, who have received an analgesia in the previous 24 hours including Paracetamol (so as not to affect the response to painful stimuli during immunization), who cannot receive their immunization due to the presence of immunization risk factors as determined by the immunization nurse, who are not able to receive a sugar solution, and whose parents refuse to participate.
Key Trial Info
Start Date :
July 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2018
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04103801
Start Date
July 14 2017
End Date
April 3 2018
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternal and child health centers
Irbid, Jordan, 21110